Cabot Stock Forecast, Price & News

Cabot (NYSE:CBT) Frequently Asked Questions

Is Cabot a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last twelve months. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cabot stock.
View analyst ratings for Cabot or view top-rated stocks.

How has Cabot's stock price been impacted by Coronavirus (COVID-19)?

Cabot's stock was trading at $29.91 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CBT stock has increased by 85.4% and is now trading at $55.46.
View which stocks have been most impacted by COVID-19.

When is Cabot's next earnings date?

Cabot is scheduled to release its next quarterly earnings announcement on Monday, February 7th 2022.
View our earnings forecast for Cabot.

How were Cabot's earnings last quarter?

Cabot Co. (NYSE:CBT) released its quarterly earnings data on Sunday, November, 7th. The specialty chemicals company reported $1.11 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.03 by $0.08. The specialty chemicals company had revenue of $904 million for the quarter, compared to analyst estimates of $914.88 million. Cabot had a trailing twelve-month return on equity of 28.15% and a net margin of 7.33%. The company's quarterly revenue was up 37.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.68 EPS.
View Cabot's earnings history.

How often does Cabot pay dividends? What is the dividend yield for Cabot?

Cabot announced a quarterly dividend on Friday, November 12th. Shareholders of record on Friday, November 26th will be paid a dividend of $0.37 per share on Friday, December 10th. This represents a $1.48 annualized dividend and a yield of 2.67%. The ex-dividend date is Wednesday, November 24th. This is an increase from Cabot's previous quarterly dividend of $0.35.
View Cabot's dividend history.

Is Cabot a good dividend stock?

Cabot pays an annual dividend of $1.48 per share and currently has a dividend yield of 2.77%. Cabot does not yet have a strong track record of dividend growth. The dividend payout ratio of Cabot is 34.10%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cabot will have a dividend payout ratio of 24.96% next year. This indicates that Cabot will be able to sustain or increase its dividend.
View Cabot's dividend history.

What guidance has Cabot issued on next quarter's earnings?

Cabot updated its FY 2022 earnings guidance on Monday, November, 29th. The company provided earnings per share guidance of $5.200-$5.600 for the period, compared to the Thomson Reuters consensus estimate of $5.520. The company issued revenue guidance of -.

What price target have analysts set for CBT?

7 brokers have issued 12 month target prices for Cabot's stock. Their forecasts range from $62.00 to $143.00. On average, they anticipate Cabot's stock price to reach $81.86 in the next twelve months. This suggests a possible upside of 47.6% from the stock's current price.
View analysts' price targets for Cabot or view top-rated stocks among Wall Street analysts.

Who are Cabot's key executives?

Cabot's management team includes the following people:

• Sean D. Keohane, President, Chief Executive Officer & Director
• Erica J. McLaughlin, Chief Financial Officer & Senior Vice President
• Patricia Hubbard, Chief Technology Officer & Senior Vice President
• Hobart C. Kalkstein, SVP & President-Reinforcement Materials segment
• Karen A. Kalita, Senior Vice President & General Counsel

What is Sean Keohane's approval rating as Cabot's CEO?

40 employees have rated Cabot CEO Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among Cabot's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Cabot's key competitors?

Some companies that are related to Cabot include LyondellBasell Industries (LYB), Westlake Chemical (WLK), Kronos Worldwide (KRO), Hawkins (HWKN), Koppers (KOP), Tredegar (TG) and Trecora Resources (TREC).
View all of CBT's competitors.

What other stocks do shareholders of Cabot own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

What is Cabot's stock symbol?

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Who are Cabot's major shareholders?

Cabot's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.67%), Fuller & Thaler Asset Management Inc. (6.05%), LSV Asset Management (4.46%), Wellington Management Group LLP (4.41%), Victory Capital Management Inc. (3.91%) and Dimensional Fund Advisors LP (3.02%). Company insiders that own Cabot stock include Hobart Kalkstein and Karen A Kalita.
View institutional ownership trends for Cabot.

Which institutional investors are selling Cabot stock?

CBT stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Citigroup Inc., BlackRock Inc., Millennium Management LLC, Cubist Systematic Strategies LLC, Renaissance Technologies LLC, LSV Asset Management, and Arrowstreet Capital Limited Partnership.
View insider buying and selling activity for Cabot or view top insider-selling stocks.

Which institutional investors are buying Cabot stock?

CBT stock was purchased by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., Victory Capital Management Inc., Peregrine Capital Management LLC, Grantham Mayo Van Otterloo & Co. LLC, Wellington Management Group LLP, Tudor Investment Corp Et Al, Hillsdale Investment Management Inc., and Deutsche Bank AG.
View insider buying and selling activity for Cabot or or view top insider-buying stocks.

How do I buy shares of Cabot?

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cabot's stock price today?

One share of CBT stock can currently be purchased for approximately $55.46.

How much money does Cabot make?

Cabot has a market capitalization of $3.15 billion and generates $3.41 billion in revenue each year. The specialty chemicals company earns $250 million in net income (profit) each year or $4.34 on an earnings per share basis.

How many employees does Cabot have?

Cabot employs 4,500 workers across the globe.

What is Cabot's official website?

The official website for Cabot is www.cabot-corp.com.

Where are Cabot's headquarters?

Cabot is headquartered at TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210.

How can I contact Cabot?

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at (617) 345-0100, via email at [email protected], or via fax at 617-342-6103.